CliffBio
small molecule

THALLOUS CHLORIDE TL 201

THALLOUS CHLORIDE TL-201

Loss of exclusivity—loss of exclusivity
CompanyLantheus Medical Imaging →See this company's full patent-cliff portfolio

Drug detail

Brand nameTHALLOUS CHLORIDE TL 201
Active ingredientTHALLOUS CHLORIDE TL-201
Strength2mCi/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formINJECTABLE
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalOctober 1998
Marketing statusDISCN

More from Lantheus Medical Imaging

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

THALLOUS CHLORIDE TL 201 patent cliff — loss of exclusivity — | CliffBio